|
|
||||||||
The Journal of Immunology, Vol 138, Issue 8 2576-2580, Copyright © 1987 by American Association of Immunologists
ARTICLES |
K Yukawa, H Kikutani, H Owaki, K Yamasaki, A Yokota, H Nakamura, EL Barsumian, RR Hardy, M Suemura and T Kishimoto
Two independent L cell transformants expressing human lymphocyte Fc epsilon R were established by using cellular DNA from RPMI 8866 cells. The surface expression of the receptor was confirmed on the basis of the binding of a panel of anti-Fc epsilon R antibodies and its ability to bind IgE. Anti-CD23 antibodies strongly stained the transformants, indicating possible identity or antigenic relationship between Fc epsilon R and CD23. This interesting observation warrants additional clarification as to the role of CD23 and Fc epsilon R in B cell differentiation.
This article has been cited by other articles:
![]() |
E. A. Hayashi, S. Akira, and A. Nobrega Role of TLR in B Cell Development: Signaling through TLR4 Promotes B Cell Maturation and Is Inhibited by TLR2 J. Immunol., June 1, 2005; 174(11): 6639 - 6647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Payet, E. C. Woodward, and D. H. Conrad Humoral Response Suppression Observed with CD23 Transgenics J. Immunol., July 1, 1999; 163(1): 217 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hunot, N. Dugas, B. Faucheux, A. Hartmann, M. Tardieu, P. Debre, Y. Agid, B. Dugas, and E. C. Hirsch Fcepsilon RII/CD23 Is Expressed in Parkinson's Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-alpha in Glial Cells J. Neurosci., May 1, 1999; 19(9): 3440 - 3447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kelly, B.-H. Chen, E. C. Woodward, and D. H. Conrad Production of a Chimeric Form of CD23 That Is Oligomeric and Blocks IgE Binding to the Fc{epsilon}RI J. Immunol., December 15, 1998; 161(12): 6696 - 6704. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. White, B. W. Ozanne, P. Graber, J.-P. Aubry, J.-Y. Bonnefoy, and W. Cushley Inhibition of Apoptosis in a Human Pre-B-Cell Line by CD23 Is Mediated Via a Novel Receptor Blood, July 1, 1997; 90(1): 234 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Barcellini, G. Rizzardi, M. Borghi, F. Nicoletti, C. Fain, N. Del Papa, and P. Meroni In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity Lupus, April 1, 1996; 5(2): 139 - 145. [Abstract] [PDF] |
||||
![]() |
L Flores-Romo, J Shields, Y Humbert, P Graber, J. Aubry, J. Gauchat, G Ayala, B Allet, M Chavez, H Bazin, et al. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23 Science, August 20, 1993; 261(5124): 1038 - 1041. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |